Clinical trial No longer in our active list Interventional Ages 18 to 60

Comparing Propofol and Dexmedetomidine for Reducing Postoperative Nausea and Vomiting

Official title: The Effect of Propofol Versus Dexmedetomidine on the Incidence of Postoperative Nausea and Vomiting in Ureteroscopic Procedures Under Spinal Anesthesia

Run by Cairo University · NCT05875077 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether using propofol or dexmedetomidine can help reduce nausea and vomiting after surgery for patients at higher risk for these issues.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment45 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
Trial IDNCT05875077 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are patients aged 18 to 60 years scheduled for ureteroscopic procedures who have more than one risk factor for postoperative nausea and vomiting.

Probably not a fit

Patients with contraindications for spinal anesthesia or those with a history of allergy to propofol or dexmedetomidine may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of propofol infusion versus dexmedetomidine infusion in reducing the incidence of postoperative nausea and vomiting (PONV) in patients undergoing ureteroscopic procedures under spinal anesthesia. It focuses on patients aged 18 to 60 years who have multiple risk factors for PONV, such as being female, having a history of PONV, and being non-smokers. The study aims to understand the mechanisms by which these medications may alleviate nausea and vomiting post-surgery, considering the physiological effects of regional anesthesia on the body. By analyzing the outcomes, the study seeks to improve patient recovery experiences and satisfaction.

Why it matters

Potential benefit: If successful, this study could significantly reduce the incidence of postoperative nausea and vomiting, leading to faster recovery and higher patient satisfaction.

How similar studies have gone: Previous studies have explored the effects of propofol and dexmedetomidine on PONV, indicating potential benefits, but this specific comparison in the context of ureteroscopic procedures is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 18 to 60 years
* ASA physical status I-II
* Scheduled for ureteroscopic procedure
* With more than one Risk factor for PONV (female, history of PONV, non-smoking).

Exclusion Criteria:

* Patients with contraindications for spinal anesthesia including infection at the injection site, bleeding diathesis, known left ventricular outflow obstruction, hypovolemia, and increased intracranial pressure.
* History of allergy or hypersensitivity to propofol or dexmedetomidine.
* Gastrointestinal diseases e.g. gastroenteritis and gastric ulcers, ear diseases e.g. infections of middle and inner ear, liver cirrhosis.
* Those who have received antiemetic drugs within 48 hours before surgery.
* Operations lasting more than two hours.
* The patient's unwillingness.

Where it's running

  • Kasralaini Medical School
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.